KARI WALEN: Open Payments
NPI 1053969451 · PUYALLUP, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,426 in 84 payments from 13 companies in 2025. Trend: 2023 $1,790 · 2024 $1,122 · 2025 $1,426
Food & beverage: $1,426
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $407 |
| Novartis Pharmaceuticals Corporation | 27 | $367 |
| Amgen Inc. | 10 | $178 |
| E.R. Squibb & Sons, L.L.C. | 5 | $105 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $80 |
| GENZYME CORPORATION | 2 | $74 |
| Regeneron Healthcare Solutions, Inc. | 2 | $59 |
| Organon LLC | 4 | $44 |
| Galderma Laboratories, L.P. | 2 | $31 |
| UCB, Inc. | 1 | $25 |
Products named: COSENTYX, SKYRIZI, OTEZLA, RINVOQ, DUPIXENT, Sotyktu, ILUMYA, Rhapsido.
Industry payments across WA — which companies pay providers there.
